Oxaliplatin exerts a synergistic effect against advanced colorectal cancer in combination with 5-fluorouracil (5-FU) and with leucovorin in the p53-proficient colorectal cancer cell line HCT116 [33]. The gene discussed is TP53; the disease is colorectal cancer.